|
|
||||||||
Department of Virology, Wellcome Biotechnology, Langley Court, Beckenham, Kent BR3 3BS, U.K.
We recently reported the enhanced immunogenicity of a peptide epitope when it was presented as a fusion protein with hepatitis B core antigen. In those experiments the fusion protein was expressed in vaccinia virus. We have now refined the system so that large amounts of highly immunogenic particles can be produced using a simple bacterial expression system. We describe the expression of three different viral epitopes as chimeric particles that induce good antibody responses to each epitope after one dose of low amounts of antigen. Finally we demonstrate that the immunogenicity is a reflection of both T helper cell sites within the core protein and also the particulate nature of the immunogens.
Received 4 November 1989;
accepted 10 January 1990.
This article has been cited by other articles:
![]() |
E. K.-W. Hui, Y. S. Yi, and S. J. Lo Hepatitis B viral core proteins with an N-terminal extension can assemble into core-like particles but cannot be enveloped J. Gen. Virol., October 1, 1999; 80(10): 2647 - 2659. [Abstract] [Full Text] |
||||
![]() |
F. Preugschat, D. R. Averett, B. E. Clarke, and D. J.T. Porter A Steady-state and Pre-steady-state Kinetic Analysis of the NTPase Activity Associated with the Hepatitis C Virus NS3 Helicase Domain J. Biol. Chem., October 4, 1996; 271(40): 24449 - 24457. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |